MC

Min Cui

North America, California, United States, San Francisco

Description

Min Cui, PhD, is the Founder and Managing Director of Decheng Capital. He is a member of the Board of Directors of AccuraGen, Ariagen, ARMO ...

Investor Profile

Min Cui has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Clinical Trials.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Clinical Trials
  • Health Care
  • Innovation Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Min Cui frequently co-invest with?

GL Ventures LLC
Asia, Beijing, China, Beijing
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 1
Decheng Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Shenzhen Capital Group
Asia, Hunan, China, Nanshan
Co-Investments: 1

What are some of recent deals done by Min Cui?

Bioheng

Nanjing, Jiangsu, China

Bioheng is a high-tech R&D innovation company.

BiopharmaBiotechnologyClinical TrialsHealth CareInnovation Management
Series BMar 24, 2021
Amount Raised: $79,698,372